Olaparib
Information about Olaparib
Olaparib Uses
Olaparib is used in the treatment of ovarian cancer and breast cancer.
How Olaparib works
Olaparib is an anticancer medication. It works by inhibiting the growth of select tumor cell lines in vitro and decrease tumor growth in both as monotherapy or following chemotherapy.
Common side effects of Olaparib
Nausea, Vomiting, Fatigue, Diarrhea, Loss of appetite, Headache, Anemia (low number of red blood cells), Decreased blood cells (red cells, white cells, and platelets), Taste change, Cough, Breathlessness, Indigestion, Abdominal pain
Medicine brands for Olaparib
OlapzaIntas Pharmaceuticals Ltd
₹39371 variant(s)
LynparzaAstraZeneca
₹40620 to ₹410252 variant(s)
OlaparibGlenmark Pharmaceuticals Ltd
₹120841 variant(s)
IbyraZydus Healthcare Limited
₹13120 to ₹140572 variant(s)
BracanatNatco Pharma Ltd
₹17343 to ₹210933 variant(s)
LynzaHetero Healthcare Limited
₹5718 to ₹77152 variant(s)
CanribAdley Formulations
₹9000 to ₹129372 variant(s)
LupiparpLupin Ltd
₹16406 to ₹228752 variant(s)
OlanamoShivnaam Tradelink Llp
₹426561 variant(s)
ObparpCipla Ltd
₹1875 to ₹20082 variant(s)
Expert advice for Olaparib
- Take Olaparib exactly as prescribed by your doctor. Do not alter your dose without consulting your doctor.
- Drinking plenty of fluids can help reduce some side effects, such as nausea and vomiting. Try to drink at least 8-10 glasses of water each day.
- Olaparib can affect your blood cell counts. Ensure you have regular blood tests as recommended by your doctor to monitor for potential issues like anemia or low white blood cell counts.
- Olaparib can harm an unborn baby. Women should use effective contraception during treatment and for a period after the last dose. Men with female partners of reproductive potential should also use effective contraception during treatment and for a specified time afterward.
- Maintain a healthy lifestyle by eating a balanced diet, getting regular exercise, and managing stress. This can help improve your overall well-being during treatment.